Login
$ASMB
$21.29 +$0.17 (0.8%) Live

$ASMB SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 10-Q
12 Nov 2026 8-K: Results of Operations and Financial Condition
03 Nov 2026 Form 4: Bjorkquist Jeanette M, PFO and PAO

Received 3,840 shares as a grant or award · Sold 727 shares ($14.3K)

03 Nov 2026 Form 4: White Nicole S, Chief Manufacturing Officer

Received 13,705 shares as a grant or award · Sold 2,593 shares ($50.9K)

03 Nov 2026 Form 4: Delaney William E Iv, Chief Scientific Officer

Received 13,705 shares as a grant or award

03 Nov 2026 Form 4: Gaggar Anuj, Chief Medical Officer

Received 13,705 shares as a grant or award · Sold 2,593 shares ($50.9K)

03 Nov 2026 Form 4: Okazaki Jason A, Director

Received 38,380 shares as a grant or award · Sold 6,202 shares ($122K)

02 Nov 2026 144
02 Nov 2026 144
02 Nov 2026 144
20 Aug 2026 S-8
14 Aug 2026 SCHEDULE 13G/A
14 Aug 2026 8-K/A: Results of Operations and Financial Condition

– Expanded ABI-6250 clinical development into cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) –

13 Aug 2026 10-Q
13 Aug 2026 8-K: Completion of Acquisition or Disposition of Assets

– Expanded ABI-6250 clinical development into cholestatic liver diseases, including primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) –

13 Aug 2026 SCHEDULE 13G/A
04 Aug 2026 SCHEDULE 13G/A
18 Jun 2026 Form 4: Bjorkquist Jeanette M, PFO and PAO

Sold 29 shares ($674)

05 Jun 2026 Form 4: Gaggar Anuj, Chief Medical Officer

Received 14,000 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support